Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Heart and Vessels
Metadata
Title
Spontaneous coronary artery dissection: a review of the etiology and available treatment options
Authors
Andrew B. McCann
Robert J. Whitbourn
Publication date
01-11-2009
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 6/2009
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-009-1153-2

Other articles of this Issue 6/2009

Heart and Vessels 6/2009 Go to the issue

Original Article

Ischemia/reperfusion is an independent trigger for increasing myocardial content of mRNA B-type natriuretic peptide

Original Article

Aging-related arterial-cardiac interaction in Japanese men

Original Article

Prevalence of venous thromboembolism in neurosurgical patients

Original Article

Improvement in the quality of the cardiac vein images by optimizing the scan protocol of multidetector-row computed tomography

Original Article

Factors related to in-hospital heart failure are very different for unstable angina and non-ST elevation myocardial infarction

Case Report

Diffuse fibromuscular dysplasia successfully treated with scoring balloon angioplasty in a 3-year-old boy

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits